EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $318,000 | -30.3% | 6,635 | -33.1% | 0.02% | -39.3% |
| Q1 2020 | $456,000 | -28.1% | 9,920 | -6.0% | 0.03% | +12.0% |
| Q4 2019 | $634,000 | +17.6% | 10,550 | +10.8% | 0.02% | +4.2% |
| Q3 2019 | $539,000 | -42.1% | 9,525 | -43.0% | 0.02% | -33.3% |
| Q2 2019 | $931,000 | -35.3% | 16,725 | -12.1% | 0.04% | +2.9% |
| Q2 2018 | $1,440,000 | +14.1% | 19,030 | -20.6% | 0.04% | +25.0% |
| Q1 2018 | $1,262,000 | -9.1% | 23,955 | -7.9% | 0.03% | 0.0% |
| Q4 2017 | $1,389,000 | -11.0% | 26,005 | -0.7% | 0.03% | -12.5% |
| Q3 2017 | $1,561,000 | – | 26,180 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |